CDK9-IN-1
Modify Date: 2024-01-14 20:09:51
CDK9-IN-1 structure
|
Common Name | CDK9-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 1415559-43-1 | Molecular Weight | 499.54100 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H21N5O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CDK9-IN-1CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87. |
| Name | N-[5-[[6-[3-(1,3-dioxoisoindol-2-yl)phenyl]pyrimidin-4-yl]amino]-2-methylphenyl]methanesulfonamide |
|---|---|
| Synonym | More Synonyms |
| Description | CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87. |
|---|---|
| Related Catalog | |
| Target |
CDK9/CycT1:39 nM (IC50) |
| In Vitro | CDK9-IN-1 is a potent CDK9 inhibitor that shows high activity against HIV-1 replication[1]. |
| References |
| Molecular Formula | C26H21N5O4S |
|---|---|
| Molecular Weight | 499.54100 |
| Exact Mass | 499.13100 |
| PSA | 129.74000 |
| LogP | 5.65950 |
| Storage condition | 2-8℃ |
| CS-0456 |
| CDK9 inhibitor |
| CDK9-IN-1 |